FDA finalizes 12-digit NDC format: What it means for the pharma supply chain

The U.S. Food and Drug Administration (FDA) has finalized its rule, “Revising the National Drug Code Format and Drug Label Barcode Requirements,” establishing a uniform 12-digit National Drug Code (NDC) format for drugs marketed in the United States. This marks one of the most significant structural changes to drug identification in decades—and it will have broad operational, labeling and systems implications across the pharmaceutical supply chain.

What’s changing

Today, FDA-assigned NDCs are 10-digit identifiers that appear in multiple configurations. Under the final rule, the FDA will adopt a uniform 12-digit NDC format.

• All newly assigned NDCs will be 12 digits
• All previously assigned 10-digit NDCs will be converted to the 12-digit format
• The change applies to human drugs (including biologics) and animal drugs
• The rule affects only FDA-assigned NDCs (not HIPAA 11-digit reimbursement formats)

Below is a high-level synopsis of what manufacturers, CDMOs/CMOs, repackagers and other supply chain partners can expect as the industry transitions.

The Timeline

March 5, 2026 – March 6, 2033

The FDA will continue assigning 10-digit NDCs. This seven-year runway is intended to allow:

• System upgrades
• Infrastructure changes
• Label redesign
• Process adjustments

March 7, 2033 (Effective Date)

Beginning on that date:

• FDA will assign only 12-digit NDCs
• Existing 10-digit NDCs will be converted to 12 digits
• Systems and labeling must support the new format

March 7, 2033 – March 6, 2036

Three-year transition period for labeling. During this period:

• “FDA does not intend to object to continued use of 10-digit NDCs on labeling”
• Companies must begin using 12-digit NDCs as soon as feasible
• “After March 7, 2036, products introduced into interstate commerce with 10-digit NDC labels may be subject to regulatory action”

Labeling Impacts

Companies must update labeling to reflect the 12-digit format by:

• Adding leading zeros to the code
• Ensuring updated labels are ready by the effective date
• Managing inventory of legacy label stock during the transition
• For most organizations, this means:
• Updating every product label
• Determining level of revalidation required
• Coordinating artwork updates across global SKUs
• Aligning master data with packaging execution systems

Systems & Infrastructure Implications

The FDA is encouraging all supply chain trading partners to begin preparing now. Affected systems can include:

• ERP platforms
• Serialization (L1–L4) systems
• Warehouse management systems
• Government reporting interfaces
• Data lakes and analytics platforms

This is not simply a label update—it is an enterprise data event.

Exceptions

Certain specified biologics (e.g., select HCT/Ps) may continue to use alternative NDC formats approved by FDA.

What this means for the industry

This change will have sweeping impacts across the pharmaceutical landscape, including:

• Modifying labels for every marketed product
• Updating data storage structures across enterprise systems
• Aligning serialization hierarchies
• Coordinating changes across CDMOs and 3PLs
• Revalidating production environments

For companies operating complex partner networks, this transition introduces both risk and opportunity:

• Risk of data mismatches during transition
• Risk of packaging delays
• Risk of system incompatibilities
• Opportunity to modernize data governance
• Opportunity to rationalize barcode strategy

Systech’s perspective

At Systech, we have been actively engaged in industry discussions surrounding the 12-digit NDC transition. We participated in industry working groups evaluating the operational implications of the change and were a signatory on the industry letter submitted to FDA and HHS leadership regarding the transition.

We are planning for full 12-digit NDC support across the Systech technology stack—with significant runway to allow our customers to plan, test and implement without disruption. This will be a major topic of conversation at industry events this year, including the upcoming HDA DMC conference in Austin, where it is expected to be front and center.

Start preparing now. Here are some practical steps your organization can take:

1. Conduct system impact assessments
2. Plan label update strategies
3. Align internal IT and regulatory roadmaps
4. Identify database and interface constraints
5. Map serialization data dependencies
6. Engage CDMOs and supply chain partners

The seven-year runway may seem long—but label change cycles, validation processes and partner coordination can compress timelines quickly.

Let’s continue the conversation

Serialization compliance is evolving. Operational readiness will define who navigates the transition smoothly.

We’re currently developing additional materials to help customers understand the practical implications and transition strategies for the 12-digit NDC shift. If you have questions, the Systech team is ready to provide guidance.

More to come as industry dialogue progresses…